Table 1.
Patient background
| Total (n=60) | HLA-A24 (+) (n=35) | HLA A24 (-) (n=25) | ||
|---|---|---|---|---|
| Age(year) |
61.8±7.6 |
62.3±7.1 |
61.1±8.2 |
NS |
| Male: Female |
53/7 |
32/3 |
21/4 |
NS |
| Prior therapy |
|
|
|
|
| Operation |
29(48%) |
19(54%) |
10(40%) |
NS |
| Radiation |
48(80%) |
26(74%) |
22(88%) |
NS |
| Chemotheraphy |
|
|
|
|
| 5FU |
59(98%) |
35(100%) |
24(96%) |
NS |
| CDDP |
58(97%) |
33(94%) |
23(92%) |
NS |
| Docetaxel | 54(90%) | 31(91%) | 23(92%) | NS |
NS not significant between the HLA-A24(+) and HLA-A24(-) group.